title: Ponatinib (Inclusig) marketing and sales suspended.
mesh_terms: D017277:Drug Approval; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D004348:Drug Labeling; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects*; D047428:Protein Kinase Inhibitors / Q000009:adverse effects*; D011724:Pyridazines / Q000009:adverse effects*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D007093:Imidazoles; D047428:Protein Kinase Inhibitors; D011724:Pyridazines; C545373:ponatinib